Efficacy and safety of MR-guided adaptive simultaneous integrated boost radiotherapy to primary lesions and positive lymph nodes in the neoadjuvant treatment of locally advanced rectal cancer: a randomized controlled phase III trial-Reference-Cited by-同舟云学术

Efficacy and safety of MR-guided adaptive simultaneous integrated boost radiotherapy to primary lesions and positive lymph nodes in the neoadjuvant treatment of locally advanced rectal cancer: a randomized controlled phase III trial

Published:2024-09-12 Issue:1 Volume:19 Page:
ISSN:1748-717X
Container-title:Radiation Oncology
language:en
Short-container-title:Radiat Oncol

Author:

Wang Haohua,Zhang Xiang,Leng Boyu,Zhu Kunli,Jiang Shumei,Feng Rui,Dou Xue,Shi Fang,Xu Lei,Yue Jinbo

Funder

National Natural Science Foundation of China

Natural Science Foundation of Shandong Province

Bethune Cancer Radiotherapy Translational Medicine Research Fund

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1186/s13014-024-02506-6.pdf

Reference31 articles.

1. McCall JL, Cox MR, Wattchow DA. Analysis of local recurrence rates after surgery alone for rectal cancer. Int J Colorect Dis. 1995;10(3):126–32.

2. Bois Hd, Heim TA, Lund A. Tumor-draining lymph nodes: at the crossroads of metastasis and immunity. Sci Immunol 2021, 6(63).

3. Wo JY, Anker CJ, Ashman JB, Bhadkamkar NA, Bradfield L, Chang DT, Dorth J, Garcia-Aguilar J, Goff D, Jacqmin D, et al. Radiation Therapy for rectal Cancer: executive summary of an ASTRO Clinical Practice Guideline. Practical Radiation Oncol. 2021;11(1):13–25.

4. García-Aguilar J, Chow O, Smith DD, Marcet J, Cataldo P, Varma M, Kumar AS, Oommen S, Coutsoftides T, Hunt S, et al. Effect of adding mFOLFOX6 after neoadjuvant chemoradiation in locally advanced rectal cancer: a multicentre, phase 2 trial. Lancet Oncol. 2015;16(8):957–66.

5. Couwenberg AM, Burbach JPM, Berbee M, Lacle MM, Arensman R, Raicu MG, Wessels FJ, Verdult J, Roodhart J, Reerink O, et al. Efficacy of dose-escalated chemoradiation on complete tumor response in patients with locally advanced rectal Cancer (RECTAL-BOOST): a phase 2 Randomized Controlled Trial. Int J Radiation Oncology*Biology*Physics. 2020;108(4):1008–18.